Cargando…
Factors related to stent patency and early elimination of jaundice using bile duct stent combined with iodine-125 seed implantation in malignant obstructive jaundice
PURPOSE: Biliary stents combined with percutaneous or endoscopic ultrasound-guided iodine-125 seed implantation into primary tumor have been confirmed to relieve malignant obstructive jaundice (MOJ), and prolong patient’s stent patency. The aim of the study was to evaluate meaningful clinical applic...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924152/ https://www.ncbi.nlm.nih.gov/pubmed/36819469 http://dx.doi.org/10.5114/jcb.2022.123974 |
_version_ | 1784887836311289856 |
---|---|
author | Han, Lian-Qiang Xiao, Nian-Jun Liu, Fang Wang, Xiang-Dong Wang, Zi-Kai Li, Wen |
author_facet | Han, Lian-Qiang Xiao, Nian-Jun Liu, Fang Wang, Xiang-Dong Wang, Zi-Kai Li, Wen |
author_sort | Han, Lian-Qiang |
collection | PubMed |
description | PURPOSE: Biliary stents combined with percutaneous or endoscopic ultrasound-guided iodine-125 seed implantation into primary tumor have been confirmed to relieve malignant obstructive jaundice (MOJ), and prolong patient’s stent patency. The aim of the study was to evaluate meaningful clinical application indications and better guide the application of this technology. MATERIAL AND METHODS: Patients with MOJ, who have received bile duct stenting combined with iodine-125 ((125)I) seed implantation from October, 2010 to April, 2022, were retrospectively analyzed. Univariate and multivariate analyses were adopted to indicate factors of stent patency in MOJ and influencing factors of jaundice reduction at one week after surgery. RESULTS: A total of 90 patients were enrolled into the study, including 52 males (57.8%) and 38 females (42.2%), with a mean age of 68.66 ±12.53 years. The median stent patency was 8 months. No serious adverse events occurred during follow-up. Multivariate analysis showed that Child-Pugh score (HR = 2.221, 95% CI: 1.081-4.562), biliary infection (HR = 1.901, 95% CI: 1.084-3.335), and pre-operative jaundice duration (HR = 1.977, 95% CI: 1.106-3.533) were the independent risk factors for stent patency. Child-Pugh B/C (OR = 4.647, 95% CI: 1.080-19.982) and bile duct infection (OR = 3.583, 95% CI: 1.095-11.725) were the independent risk factors for jaundice reduction at one week after surgery. CONCLUSIONS: MOJ patients treated with biliary stents combined with (125)I seed implantation, and patients with better pre-operative liver function and no biliary tract infection, present not only longer biliary stent patency, but also better early jaundice reduction. |
format | Online Article Text |
id | pubmed-9924152 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-99241522023-02-16 Factors related to stent patency and early elimination of jaundice using bile duct stent combined with iodine-125 seed implantation in malignant obstructive jaundice Han, Lian-Qiang Xiao, Nian-Jun Liu, Fang Wang, Xiang-Dong Wang, Zi-Kai Li, Wen J Contemp Brachytherapy Original Paper PURPOSE: Biliary stents combined with percutaneous or endoscopic ultrasound-guided iodine-125 seed implantation into primary tumor have been confirmed to relieve malignant obstructive jaundice (MOJ), and prolong patient’s stent patency. The aim of the study was to evaluate meaningful clinical application indications and better guide the application of this technology. MATERIAL AND METHODS: Patients with MOJ, who have received bile duct stenting combined with iodine-125 ((125)I) seed implantation from October, 2010 to April, 2022, were retrospectively analyzed. Univariate and multivariate analyses were adopted to indicate factors of stent patency in MOJ and influencing factors of jaundice reduction at one week after surgery. RESULTS: A total of 90 patients were enrolled into the study, including 52 males (57.8%) and 38 females (42.2%), with a mean age of 68.66 ±12.53 years. The median stent patency was 8 months. No serious adverse events occurred during follow-up. Multivariate analysis showed that Child-Pugh score (HR = 2.221, 95% CI: 1.081-4.562), biliary infection (HR = 1.901, 95% CI: 1.084-3.335), and pre-operative jaundice duration (HR = 1.977, 95% CI: 1.106-3.533) were the independent risk factors for stent patency. Child-Pugh B/C (OR = 4.647, 95% CI: 1.080-19.982) and bile duct infection (OR = 3.583, 95% CI: 1.095-11.725) were the independent risk factors for jaundice reduction at one week after surgery. CONCLUSIONS: MOJ patients treated with biliary stents combined with (125)I seed implantation, and patients with better pre-operative liver function and no biliary tract infection, present not only longer biliary stent patency, but also better early jaundice reduction. Termedia Publishing House 2022-12-30 2022-12 /pmc/articles/PMC9924152/ /pubmed/36819469 http://dx.doi.org/10.5114/jcb.2022.123974 Text en Copyright © 2022 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) ) |
spellingShingle | Original Paper Han, Lian-Qiang Xiao, Nian-Jun Liu, Fang Wang, Xiang-Dong Wang, Zi-Kai Li, Wen Factors related to stent patency and early elimination of jaundice using bile duct stent combined with iodine-125 seed implantation in malignant obstructive jaundice |
title | Factors related to stent patency and early elimination of jaundice using bile duct stent combined with iodine-125 seed implantation in malignant obstructive jaundice |
title_full | Factors related to stent patency and early elimination of jaundice using bile duct stent combined with iodine-125 seed implantation in malignant obstructive jaundice |
title_fullStr | Factors related to stent patency and early elimination of jaundice using bile duct stent combined with iodine-125 seed implantation in malignant obstructive jaundice |
title_full_unstemmed | Factors related to stent patency and early elimination of jaundice using bile duct stent combined with iodine-125 seed implantation in malignant obstructive jaundice |
title_short | Factors related to stent patency and early elimination of jaundice using bile duct stent combined with iodine-125 seed implantation in malignant obstructive jaundice |
title_sort | factors related to stent patency and early elimination of jaundice using bile duct stent combined with iodine-125 seed implantation in malignant obstructive jaundice |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924152/ https://www.ncbi.nlm.nih.gov/pubmed/36819469 http://dx.doi.org/10.5114/jcb.2022.123974 |
work_keys_str_mv | AT hanlianqiang factorsrelatedtostentpatencyandearlyeliminationofjaundiceusingbileductstentcombinedwithiodine125seedimplantationinmalignantobstructivejaundice AT xiaonianjun factorsrelatedtostentpatencyandearlyeliminationofjaundiceusingbileductstentcombinedwithiodine125seedimplantationinmalignantobstructivejaundice AT liufang factorsrelatedtostentpatencyandearlyeliminationofjaundiceusingbileductstentcombinedwithiodine125seedimplantationinmalignantobstructivejaundice AT wangxiangdong factorsrelatedtostentpatencyandearlyeliminationofjaundiceusingbileductstentcombinedwithiodine125seedimplantationinmalignantobstructivejaundice AT wangzikai factorsrelatedtostentpatencyandearlyeliminationofjaundiceusingbileductstentcombinedwithiodine125seedimplantationinmalignantobstructivejaundice AT liwen factorsrelatedtostentpatencyandearlyeliminationofjaundiceusingbileductstentcombinedwithiodine125seedimplantationinmalignantobstructivejaundice |